Opinion|Videos|March 31, 2025
Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
Experts discuss the relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk, with findings from a large US population study, and explore how these findings could impact clinical practice and the management of patients at risk for ASCVD.
Advertisement
Video content above is prompted by the following:
- In the introduction, I mentioned that Lp(a) is considered an independent and significant risk factor for ASCVD and aortic stenosis. Dr Wong, you recently studied the relationship between Lp(a) level and ASCVD risk in a large US population. Could you describe your findings?
- Dr Saseen, how might findings like these impact clinical practice?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates
2
ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care
3
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
